Posted in | News | Titanium | Mining Business

Marmota Limited Commences Drilling at Muckanippie Titanium Discovery

Marmota Limited is pleased to announce that drilling has commenced at its new Heavy Minerals (HM) titanium discovery at Muckanippie in South Australia. This campaign start follows the recent announcement of bonanza-grade heavy mineral assays across every discovery hole at the site earlier this month.

Drilling Program Overview

  • Program Details: 89 planned air core drill holes targeting shallow titanium-bearing mineral sands from surface to an average depth of ~30 m.
  • Progress: Drilling began on 23 January 2025, with the first 10 holes, totaling 359m, now completed. The entire program is expected to conclude within nine days.
  • Strategic Importance: This program focuses on expanding the discovery by targeting the interpreted titanium-hosting palaeochannel, which spans approximately 28 km across Marmota’s tenements.

Highlights

  • Exceptional Assay Results:
    • WI-081: 28 m @ 19.2% HM from surface, including 4 m @ 22.2% HM.
    • WI-080: 36 m @ 13.5% HM from surface, including 4 m @ 27.8% HM.
    • WI-079: 39 m @ 13.2% HM from surface, including 4 m @ 26.0% HM.
    • WI-078: 24 m @ 13.5% HM from surface, including 4 m @ 21.3% HM.

Dr. Colin Rose, Marmota’s Executive Chairman, stated: Marmota announced just 10 days ago HM assays featuring bonanza grades in every discovery hole. Those assays confirm Marmota’s discovery at Muckanippie as a highly significant new Heavy Mineral sands discovery. Marmota is progressing with full speed a major follow-up drill program to rapidly advance, grow and develop this outstanding titanium Heavy Mineral discovery.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.